-
Friday, 06/30/2023
ISICIP 2023 E-POSTERS SUBMISSIONS
27th International Symposium on Infections in the Critically ill patient to be held on October 5-6 in Barcelona. ISICIP 2023
The deadline to submit your e-Poster is September 15th,2023
-
Friday, 04/28/2023
The viral load of COVID-19 at admission to the ICU determines the prognosis of patients
Madrid, April 26, 2023. New research reveals the importance of 'viral storm' in critical patients with COVID-19. The work is published in the journal The Lancet Microbe and has been carried out by several groups in the area of Respiratory Diseases (CIBERES) and the area of Infectious Diseases (CIBERINFEC) of the Biomedical Research Center in Network (CIBER)consortium attached to the Carlos III Health Institute (ISCIII). The results show that viral load in blood at admission to the ICU is a determining factor in the prognosis of critical patients with COVID-19.
-
Thursday, 04/20/2023
33rd European Congress of Clinical Microbiology and Infectious Diseases
33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark April 15-18, 2023
Our researchers have participated in the Congress with oral sessions, presentations and many posters you can see following:
-
Wednesday, 04/05/2023
Specific clinical guidelines published for severe community-acquired pneumonia
Researchers from the Hospital Clínic-IDIBAPS have co-led a document on the management of severe community-acquired pneumonia, published simultaneously in the European Respiratory Journal and Intensive Care Medicine.
These are clinical guidelines that provide recommendations to standardize the treatment and management of the most critical patients.
-
Monday, 03/27/2023
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
On February 14th, 2023, an article was published in the journal Critical Care titled "Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia". This study, conducted by an international team of researchers led by Dr. Antoni Torres, focuses on the treatment of pneumonia caused by Pseudmonas aeruginosa.
-
Friday, 01/20/2023
Researchers from IAMR group publish in Nature Biotechnology a ‘Living medicine’ created to tackle drug-resistant lung infections.
This excellent result comes from a collaborative consortium in which our IDIBAPS-Ciberes group added an important translational value on this new promising technology developed by CRG, also with the collaboration of Institute of Agrobiotechnology (IdAB), a joint research institute of Spain’s CSIC and the government of Navarre. https://www.nature.com/articles/s41587-022-01584-9#citeas.
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria which is naturally resistant to many types of antibiotics and is a common source of infections in hospitals.
The treatment involves using a modified version of the bacterium Mycoplasma pneumoniae, removing its ability to cause disease and repurposing it to attack P. aeruginosa instead. The modified bacterium is used in combination with low doses of antibiotics that would otherwise not work on their own.
Researchers tested the efficacy of the treatment in mice, finding that it significantly reduced lung infections. The ‘living medicine’ doubled mouse survival rate compared to not using any treatment. Administering a single, high dose of the treatment showed no signs of toxicity in the lungs. Once the treatment had finished its course, the innate immune system cleared the modified bacteria in a period of four days.
-
Wednesday, 01/18/2023
Anna Motos Galera read her doctoral thesis
Anna Motos Galera read her doctoral thesis
Anna Motos read her doctoral thesis on December 21st 2022 at the Faculty of Medicine of the University of Barcelona. Her thesis entitled: Novel antimicrobial agents and therapeutic approaches for nosocomial pneumonia caused by Pseudomonas aeruginosa has obtained the Cum Laude qualification.
Congratulations Anna!
-
Thursday, 11/17/2022
New doctoral thesis read!
Congratulations Rubén López
New doctoral thesis read!
Rubén López Aladid read his doctoral thesis on October 20th at the Faculty of Biology of the University of Barcelona. His thesis entitled: The role of the microbiota in patients with bronchiectasis not associated with cystic fibrosis has obtained the Cum Laude qualification.
Congratulations Rubén!
-
Thursday, 10/20/2022
Welcome to new fellow researchers!
New stays in the Research Group
Mariana Bichuette Cartuliares
Respiratory physiotherapist, MSc. in health science, and Ph.D. student in emergency medicine.
From Denmark, staying here from the 1st to the 21st of October 2022.
During her study stay, she is learning about diagnostics methods including animal research and FilmArray. In addition, She is learning and assisting in the microbiological culture of lower respiratory specimens and biopsies.
-
Thursday, 10/20/2022
Welcome to new fellow researchers!
Francisco José Molina Saladriga
PhD student, MSc. Specialist in critical care medicine.
From Medellin, Colombia. Staying from October 11 to November 24, 2022
He is learning from molecular biology techniques: FilmArray and microbiome in pneumonia.
